ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,995Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 71

$1.58M Total Retail Price of All Prescriptions

Rank: 4 out of 71

1,071 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,071 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 8,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 34%.

Prescription Price

$113 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
GABAPENTIN 855 421 1 3
NAMENDA 786 772 2 2
DONEPEZIL HCL 746 676 3 1
GALANTAMINE HBR 611 501 10 4 5
TRAMADOL HCL-ACETAMINOPHEN 404 136 5 11
CITALOPRAM HBR 402 339 6 10
METHOCARBAMOL 363 72 R 7 64
SIMVASTATIN 320 202 8 13
LYRICA 312 88 9 12
EXELON 258 246 10 6
PRAMIPEXOLE DIHYDROCHLORIDE 251 193 11 8
MELOXICAM 227 80 12 56
DIVALPROEX SODIUM 221 160 13 26
RANITIDINE HCL 210 90 14 24
CYMBALTA 210 71 14 16
ZOLPIDEM TARTRATE 207 119 16 15
LAMOTRIGINE 207 57 16 21
SERTRALINE HCL 198 148 18 7
FLECTOR 186 67 19 99
AMLODIPINE BESYLATE 184 158 20 59
SYNTHROID 163 87 21 55
PROPRANOLOL HCL 162 102 22 32
METAXALONE 157 23 R 10 23 65
NABUMETONE 151 73 24 31
TRAZODONE HCL 148 95 25 50
OMEPRAZOLE 144 53 26 36
LEVOTHYROXINE SODIUM 140 109 27 61
ZETIA 139 80 28 90
AZILECT 108 87 29 47
PLAVIX 107 89 30 20
CELEBREX 104 81 31 124
QUETIAPINE FUMARATE 102 85 32 14
ABILIFY 97 51 33 84
LANSOPRAZOLE 97 41 33 107
CARBIDOPA-LEVODOPA 94 84 35 4
METFORMIN HCL 91 46 36 106
ARICEPT 90 90 37 92
CLOPIDOGREL 90 75 37 19
LOSARTAN POTASSIUM 88 66 39 52
ESCITALOPRAM OXALATE 86 52 40 73
PRISTIQ ER 85 72 41 93
AMITRIPTYLINE HCL 84 18 R 42 18
RISPERIDONE 84 63 42 22
PRIMIDONE 83 54 44 23
DIOVAN 72 51 45 136
RIVASTIGMINE 72 54 45 42
TIZANIDINE HCL 66 22 47 17
ORPHENADRINE CITRATE 66 25 R 47 39
ENALAPRIL MALEATE 64 32 49 48
ATORVASTATIN CALCIUM 64 28 49 86
GLIMEPIRIDE 63 38 51 141
LEVETIRACETAM 62 0 52 9
ATENOLOL 62 46 52 115
TOPIRAMATE 60 13 54 29
CARBAMAZEPINE 60 44 54 57
LIDODERM 59 0 56 145
CHLORZOXAZONE 58 15 R 57 117
TRAMADOL HCL 57 23 58 30
CYCLOBENZAPRINE HCL 57 0 R 58 66
BUSPIRONE HCL 57 31 58 62
ALENDRONATE SODIUM 57 33 58 117
OLANZAPINE 53 49 62 123
CRESTOR 53 31 62 107
DILANTIN 52 11 64 28
TRILIPIX 51 24 65 153
WELCHOL 51 22 65 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.